Overexpression of epithelial growth factor receptor (EGFR) predicts better response to neo-adjuvant chemotherapy in patients with triple-negative breast cancer

Table 3 Correlations between Pathologic Response and Clinicopathological Characteristics in Patients with TNBCs

Factors	pCR	RD	OR^‡	P^*	P^#
	No. of Patients	No. of Patients	(95% CI^†)
Age, years
≤35	0	0	/	/	/
>35	10	30	/
Menstrual Status
Postmenopause	2	14	0.38	0.263	1.000
Premenopause	8	16	(0.09 - 1.54)
Histology
Ductal	10	28	1.62	1.000	1.000
Nonductal	0	2	(0.12 - 21.37)
Prechemotherapy N stage
N0	6	20	0.81	0.718	1.000
N1- N3	4	10	(0.27 - 2.39)
Histological grade
I - II	6	12	1.83	0.300	1.000
III	4	18	(0.61- 5.51)
EGFR
Positive	10	0	59.18	< 0.001	0.714
Negative	0	30	(3.77- 927.97)

ISSN: 1479-5876